305 related articles for article (PubMed ID: 15144905)
21. [Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter].
Bois-Joyeux B; Thomassin H; Richard F; Ikonomova R; Denissenko M; Danan JL
Bull Cancer; 1995 Jul; 82(7):541-50. PubMed ID: 7549116
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of the alpha-foetoprotein gene in fibroblasts: identification and characterization of cis and trans elements.
Henriette MF; Gabant P; Dreze PL; Szpirer C; Szpirer J
Folia Biol (Praha); 1997; 43(1):5-13. PubMed ID: 9158943
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
25. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells.
He P; Tang ZY; Ye SL; Liu BB; Liu YK
J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816
[TBL] [Abstract][Full Text] [Related]
26. GATA-4, GATA-5, and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1alpha.
Divine JK; Staloch LJ; Haveri H; Jacobsen CM; Wilson DB; Heikinheimo M; Simon TC
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1086-99. PubMed ID: 14715527
[TBL] [Abstract][Full Text] [Related]
27. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
29. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma.
Wang W; Hayashi Y; Ninomiya T; Ohta K; Nakabayashi H; Tamaoki T; Itoh H
J Pathol; 1998 Mar; 184(3):272-8. PubMed ID: 9614379
[TBL] [Abstract][Full Text] [Related]
30. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the human protein S gene promoter by liver enriched transcription factors.
Hall AJ; Peake IR; Winship PR
Br J Haematol; 2006 Nov; 135(4):538-46. PubMed ID: 17061980
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of alpha-fetoprotein gene expression.
Lazarevich NL
Biochemistry (Mosc); 2000 Jan; 65(1):117-33. PubMed ID: 10702646
[TBL] [Abstract][Full Text] [Related]
33. Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
Hida D; Nakata K; Shima Y; Migita K; Nakao K; Kato Y; Ishii N; Eguchi K
Anticancer Res; 1998; 18(6A):4317-22. PubMed ID: 9891485
[TBL] [Abstract][Full Text] [Related]
34. Developmental changes in the expression of the liver-enriched transcription factors LF-B1, C/EBP, DBP and LAP/LIP in relation to the expression of albumin, alpha-fetoprotein, carbamoylphosphate synthase and lactase mRNA.
Van den Hoff MJ; Vermeulen JL; De Boer PA; Lamers WH; Moorman AF
Histochem J; 1994 Jan; 26(1):20-31. PubMed ID: 7513319
[TBL] [Abstract][Full Text] [Related]
35. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
[TBL] [Abstract][Full Text] [Related]
36. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes.
Hu JM; Camper SA; Tilghman SM; Miller T; Georgoff I; Serra R; Isom HC
Cell Growth Differ; 1992 Sep; 3(9):577-88. PubMed ID: 1419909
[TBL] [Abstract][Full Text] [Related]
37. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
Takikawa H; Mafune K; Hamada H; Nettelbeck DM; Müller R; Makuuchi M; Kaminishi M
Int J Oncol; 2003 May; 22(5):1051-6. PubMed ID: 12684671
[TBL] [Abstract][Full Text] [Related]
38. The alpha-fetoprotein promoter is the target of Afr1-mediated postnatal repression.
Peyton DK; Huang MC; Giglia MA; Hughes NK; Spear BT
Genomics; 2000 Jan; 63(2):173-80. PubMed ID: 10673330
[TBL] [Abstract][Full Text] [Related]
39. Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer.
Chen EQ; Song XQ; Wang YL; Zhou TY; Bai L; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2011 Mar; 65(2):125-31. PubMed ID: 21108965
[TBL] [Abstract][Full Text] [Related]
40. C/EBP and C-Myb sites are important for the functional activity of the human myeloperoxidase upstream enhancer.
Yao C; Qin Z; Works KN; Austin GE; Young AN
Biochem Biophys Res Commun; 2008 Jun; 371(2):309-14. PubMed ID: 18435917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
